Sort
51,593 grants matching “hepatitis”
Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy
$472,355Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy
$472,355Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
Mechanical control of cell growth and differentiation
$472,344Paul A Janmey · University Of Pennsylvania · R01 · FY2011 · GM
Training Program in Substance Use, HIV and Related Infections
$472,338Steffanie A Strathdee · University Of California, San Diego · T32 · FY2020 · DA
Genes Related to HCC Progression in LD and DD Transplant
$472,296Robert A Fisher · Virginia Commonwealth University · R01 · FY2009 · DK
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
$472,100Grace X Ma · Temple Univ Of The Commonwealth · R01 · FY2010 · CA
Atypical Antipsychotics: Effects on Hepatic Glucose and Lipid Metabolism in Human
$472,070Karen L Teff · Monell Chemical Senses Center · R01 · FY2010 · DK
Plasmablast trafficking and antibody response in influenza vaccination
$472,056Harry Bernard Greenberg · Stanford University · U19 · FY2012 · AI
Regulation of Hepatic Insulin Extraction
$472,036Kenneth S Polonsky · Washington University · R01 · FY2007 · DK
OFFICE BASED METHADONE PRESCRIBING II
$472,024Montefiore Medical Center (Bronx, Ny) · R01 · FY2000 · DA
Liver Pathobiology: insights through the lens of rare diseases
$471,988Silvia Vilarinho · Yale University · R01 · FY2024 · DK
Regulation of Hepatic Insulin Extraction
$471,972Kenneth S Polonsky · Washington University · R01 · FY2006 · DK
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2021 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2020 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2024 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2022 · ES
Xenobiotic-responsive hepatic long non-coding RNAs
$471,971David J Waxman · Boston University (Charles River Campus) · R01 · FY2023 · ES
Advancing our Understanding of Rare Pediatric Liver Diseases
$471,943Barbara Anne Haber · Children'S Hosp Of Philadelphia · U01 · FY2010 · DK
Analysis of the proteome of PKD-ELVs in polycystic kidney disease and controls
$471,887Christopher J. Ward · Mayo Clinic Rochester · RC1 · FY2009 · DK
An NADH-ChREBP axis in fatty liver disease and dyslipidemia
$471,860Russell Paul Goodman · Massachusetts General Hospital · R01 · FY2025 · DK
Texas National HIV Behavioral Surveillance
$471,839Jonathan Poe · Texas State Dept Of Health Services · U1B · FY2014 · PS
Regulation of glycogen in health and disease
$471,833Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
A Randomized Trial of Hep B Screening and Vaccination in High Risk Vietnamese
$471,806Grace X Ma · Temple Univ Of The Commonwealth · R01 · FY2007 · CA
NON-INVASIVE PHYSIOLOGIC PREDICTORS OF AGGRESSIVENESS IN RENAL CELL CARCINOMA
$471,752Ivan Pedrosa · Ut Southwestern Medical Center · R01 · FY2023 · CA
ONTOGENY OF HEPATIC ION TRANSPORT
$471,724Mount Sinai School Of Medicine Of Nyu · R37 · FY2003 · HD